Mycoplasma penetrans Bacteremia and Primary Antiphospholipid Syndrome1
Antonio Yáñez* , Lilia Cedillo†, Olivier Neyrolles‡, Encarnación Alonso*, Marie-Christine Prévost‡, Jorge Rojas*, Harold L. Watson§, Alain Blanchard‡, and Gail H. Cassell§
Author affiliations: *Centro de Investigación Biomédica de Oriente-IMSS, Puebla City, Mexico;; †Benemérita Universidad Autónoma de Puebla, Puebla City, Mexico;; ‡Institut Pasteur, Paris, France;; §University of Alabama at Birmingham, Birmingham, Alabama, USA
Figure 1. Polymerase chain reaction (PCR) detection of Mycoplasma penetrans in clinical samples. A. M. penetrans PCR genomic amplification with the primers MYCPENET-P and MYCPENET-N (7) and analyzed by electrophoresis in 2% agarose gel. Lysates from the following original samples: throat swab (lane 1); tracheal aspirate (lane 2); blood (lane 3); first blood subculture (HF-1 isolate) (lane 4); M. penetrans GTU-54-6A1 (lane 5), showing the amplification product of 407-bp; and negative control (lane 6). B. Southern blotting of the same material. Hybridization with the internal oligonucleotide (MYCPENET-S) probe confirmed the specific amplification of M. penetrans genetic sequences.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.